Literature DB >> 5302335

Field study of the safety of abate for treating potable water and observations on the effectiveness of a control programme involving both abate and malathion.

E R Laws, V A Sedlak, J W Miles, C R Joseph, J R Lacomba, A Diaz Rivera.   

Abstract

Abate is a larvicide for Aedes aegypti, a vector of yellow fever, dengue, and haemorrhagic fever. It is less toxic than malathion or DDT. Tests in human volunteers had previously indicated it would be safe to add to drinking-water where the mosquito often breeds.In a 19-month test in Puerto Rico, Abate was added to the drums and cisterns in which a community of about 2000 persons stored their drinking-water. This use of Abate and other insecticidal measures (malathion spraying) gradually achieved control of A. aegypti during the first 4 months of treatment and control was maintained thereafter although the test area was surrounded by active breeding-sites. There was no accumulation of Abate in the water in spite of monthly additions of the compound. With minor exceptions, residents readily accepted this use of Abate. Careful surveillance failed to reveal any illness or significant side-effects attributable to measures adopted in the control programme. Abate is considered safe for full-scale field use according to directions.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5302335      PMCID: PMC2554476     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  Determination of the cholinesterase activity in blood and organs by automatic titration; with some observations on seious errors of the method and remarks of the photometric determination.

Authors:  J JENSEN-HOLM; H H LAUSEN; K MILTHERS; K O MOLLER
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1959

2.  Toxicology of Abate in volunteers.

Authors:  E R Laws; F R Morales; J Hayes; C R Joseph
Journal:  Arch Environ Health       Date:  1967-02

3.  Toxicology of Abate in laboratory animals.

Authors:  T B Gaines; R Kimbrough; E R Laws
Journal:  Arch Environ Health       Date:  1967-02
  3 in total
  7 in total

1.  Primary production: Depression of oxygen evolution in algal cultures by organophosphorus insecticides.

Authors:  S B Derby; E Ruber
Journal:  Bull Environ Contam Toxicol       Date:  1970-11       Impact factor: 2.151

2.  A field trial of Abate larvicide for the control of Aedes aegypti in Bangkok, Thailand.

Authors:  Y H Bang; C P Pant
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

3.  [Sensitivity of and resistance to insecticides of Aedes aegypti in West Africa and methods of control of the vector].

Authors:  J Mouchet; G Pichon; P Gayral; J Hamon
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

4.  Toxicokinetics of temephos after oral administration to adult male rats.

Authors:  Francisco Alberto Verdín-Betancourt; Mario Figueroa; Alicia Guadalupe Soto-Ramos; Ma de Lourdes López-González; Gilberto Castañeda-Hernández; Yael Yvette Bernal-Hernández; Aurora Elizabeth Rojas-García; Adolfo Sierra-Santoyo
Journal:  Arch Toxicol       Date:  2021-01-20       Impact factor: 5.153

5.  Laboratory experiments on the control of cyclops transmitting guinea worm.

Authors:  R Muller
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

Review 6.  Community-Effectiveness of Temephos for Dengue Vector Control: A Systematic Literature Review.

Authors:  Leyanna George; Audrey Lenhart; Joao Toledo; Adhara Lazaro; Wai Wai Han; Raman Velayudhan; Silvia Runge Ranzinger; Olaf Horstick
Journal:  PLoS Negl Trop Dis       Date:  2015-09-15

7.  Coverage and beliefs about temephos application for control of dengue vectors and impact of a community-based prevention intervention: secondary analysis from the Camino Verde trial in Mexico.

Authors:  José Legorreta-Soberanis; Sergio Paredes-Solís; Arcadio Morales-Pérez; Elizabeth Nava-Aguilera; Felipé René Serrano de Los Santos; Belén Madeline Sánchez-Gervacio; Robert J Ledogar; Anne Cockcroft; Neil Andersson
Journal:  BMC Public Health       Date:  2017-05-30       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.